• / Free eNewsletters & Magazine
  • / My Account
Home>Allergan's Botox gets FDA OK to treat forehead lines

Allergan's Botox gets FDA OK to treat forehead lines

Allergan's Botox gets FDA OK to treat forehead lines

10/03/2017

Allergan PLC (AGN) said Tuesday that the Food and Drug Administration has approved Botox for the temporary improvement of moderate-to-severe forehead lines. Botox is already approved for treat "crow's feet" and glabellar lines. Allergan's stock, which was still inactive in premarket trade, has tumbled 13.5% over the past three months, to be up just 0.5% year to date, while the S&P 500 has gained 4.1% over the past three months and 13.0% this year.

-Tomi Kilgore; 415-439-6400; AskNewswires@dowjones.com

 

(END) Dow Jones Newswires

10-03-17 0737ET

Copyright (c) 2017 Dow Jones & Company, Inc.

1

©2017 Morningstar Advisor. All right reserved.